Earlier this year, the FDA approved the same vaccine for the prevention of lower respiratory tract disease caused by RSV in individuals 60 years of age and older.
Due to manufacturing problems in late 2015, supplies of the US-licensed yellow fever vaccine are expected to be completely depleted by the middle of 2017. In a recent report, the CDC detailed its plan to...